Newsroom

Recent News Releases

November 23, 2018 2018-11-23 Takeda Canada and our General Manager Gamze Yüceland are featured in the November issue of Canadian Pharmaceutical Marketing (CPM)
October 23, 2018 2018-10-23 Study shows investigational subcutaneous formulation of ENTYVIO® (vedolizumab) achieves and maintains clinical remission and mucosal healing in moderately to severely active ulcerative colitis
September 10, 2018 2018-09-10 Takeda Canada Provides YourVantage™ Patient Support Program To Canadians With Metastatic Lung Cancer Prescribed Alunbrig™
July 30, 2018 2018-07-30 New Treatment Option for Canadians with Metastatic Lung Cancer
June 12, 2018 2018-06-12 Gamze Yüceland appointed General Manager of Takeda Canada
Copyright 1995-2018 Takeda Pharmaceutical Company Limited. All rights reserved.

You are about to leave the Takeda Canada website. This link is provided by Takeda as a resource to website visitors. Takeda Canada does not endorse or take responsibility for information presented on any website except its own.

Do you wish to leave this site?